These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bone mineral density in patients with familial hypocalciuric hypercalcaemia (FHH). Abugassa S; Nordenström J; Järhult J Eur J Surg; 1992 Aug; 158(8):397-402. PubMed ID: 1356477 [TBL] [Abstract][Full Text] [Related]
3. Influence of orlistat on bone turnover and body composition. Gotfredsen A; Westergren Hendel H; Andersen T Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1154-60. PubMed ID: 11486790 [TBL] [Abstract][Full Text] [Related]
4. Familial hypocalciuric hypercalcaemia. II. Intestinal calcium absorption and vitamin D metabolism. Kristiansen JH; Rødbro P; Christiansen C; Brøchner Mortensen J; Carl J Clin Endocrinol (Oxf); 1985 Nov; 23(5):511-5. PubMed ID: 4085131 [TBL] [Abstract][Full Text] [Related]
9. Bone mass as referent for urinary hydroxyproline excretion: age and sex-related changes in 125 normals and in primary hyperparathyroidism. Hyldstrup L; McNair P; Jensen GF; Nielsen HR; Transbøl I Calcif Tissue Int; 1984 Dec; 36(6):639-44. PubMed ID: 6442199 [TBL] [Abstract][Full Text] [Related]
10. Familial hypocalciuric hypercalcaemia: observations on vitamin D metabolism and parathyroid function. Davies M; Adams PH; Berry JL; Lumb GA; Klimiuk PS; Mawer EB; Wain D Acta Endocrinol (Copenh); 1983 Oct; 104(2):210-5. PubMed ID: 6314724 [TBL] [Abstract][Full Text] [Related]
11. Increased trabecular volumetric bone mass density in Familial Hypocalciuric Hypercalcemia (FHH) type 1: a cross-sectional study. Jakobsen NF; Rolighed L; Moser E; Nissen PH; Mosekilde L; Rejnmark L Calcif Tissue Int; 2014 Aug; 95(2):141-52. PubMed ID: 24894639 [TBL] [Abstract][Full Text] [Related]
12. Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women. Pødenphant J; Christiansen C; Catherwood BD; Deftos LJ Calcif Tissue Int; 1984 Sep; 36(5):536-40. PubMed ID: 6441624 [TBL] [Abstract][Full Text] [Related]
13. [An elderly case suspected of familial hypocalciuric hypercalcemia subsequent to manifestation of hypercalcemia]. Hashida H; Honda T; Morimoto H; Aibara Y; Matsumoto Y; Kurita M Nihon Ronen Igakkai Zasshi; 2002 Nov; 39(6):654-8. PubMed ID: 12518419 [TBL] [Abstract][Full Text] [Related]
14. Urinary calcium indices in primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcaemia (FHH): which test performs best? Arshad MF; McAllister J; Merchant A; Rab E; Cook J; Eastell R; Balasubramanian S Postgrad Med J; 2021 Sep; 97(1151):577-582. PubMed ID: 32892159 [TBL] [Abstract][Full Text] [Related]
15. Bone metabolism and bone status in osteoporotic patients. Hartwell D; Riis BJ; Christiansen C; Thomsen K; Johansen JS; Rødbro P Acta Med Scand; 1987; 222(5):453-8. PubMed ID: 3425398 [TBL] [Abstract][Full Text] [Related]
16. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion. Charles P; Poser JW; Mosekilde L; Jensen FT J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367 [TBL] [Abstract][Full Text] [Related]
17. Seasonal variations in indices of bone formation precede appropriate bone mineral changes in normal men. Hyldstrup L; McNair P; Jensen GF; Transbøl I Bone; 1986; 7(3):167-70. PubMed ID: 3768193 [TBL] [Abstract][Full Text] [Related]
18. Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis? Als OS; Gotfredsen A; Riis BJ; Christiansen C Ann Rheum Dis; 1985 Jun; 44(6):406-11. PubMed ID: 3874608 [TBL] [Abstract][Full Text] [Related]
19. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. Pantazi H; Papapetrou PD J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046 [TBL] [Abstract][Full Text] [Related]